Johan Weigelt

Structure-based screening and design in drug discovery.

Johan Schultz, J. Weigelt, M. Wikström, 2002, Drug discovery today.

Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor.

Natalia Markova, Ida Johansson, Tobias Karlberg, 2010, Journal of medicinal chemistry.

Site-selective screening by NMR spectroscopy with labeled amino acid pairs.

Johan Schultz, J. Weigelt, M. Wikström, 2002, Journal of the American Chemical Society.

PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3.

Sara Spjut, Anna Linusson, Mikael Elofsson, 2013, ACS chemical biology.

Structural genomics and drug discovery: all in the family.

Matthieu Schapira, Cheryl H Arrowsmith, Linda D B McBroom-Cerajewski, 2008, Current opinion in chemical biology.

Site-selective labeling strategies for screening by NMR.

Johan Schultz, J. Weigelt, M. Wikström, 2002, Combinatorial chemistry & high throughput screening.